Compare FOXF & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FOXF | CATX |
|---|---|---|
| Founded | 2007 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Motor Vehicles | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 618.2M | 569.6M |
| IPO Year | 2013 | 2018 |
| Metric | FOXF | CATX |
|---|---|---|
| Price | $16.83 | $4.23 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 9 |
| Target Price | ★ $29.20 | $12.11 |
| AVG Volume (30 Days) | 806.6K | ★ 1.4M |
| Earning Date | 05-07-2026 | 03-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,467,321,000.00 | N/A |
| Revenue This Year | N/A | $12.71 |
| Revenue Next Year | $0.90 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 5.27 | N/A |
| 52 Week Low | $13.08 | $1.60 |
| 52 Week High | $31.18 | $6.16 |
| Indicator | FOXF | CATX |
|---|---|---|
| Relative Strength Index (RSI) | 47.24 | 38.42 |
| Support Level | $15.36 | $3.24 |
| Resistance Level | $17.98 | $4.54 |
| Average True Range (ATR) | 0.72 | 0.38 |
| MACD | 0.04 | -0.16 |
| Stochastic Oscillator | 56.80 | 12.50 |
Fox Factory Holding Corp is a designer, manufacturer, and marketer of performance-defining products and systems used predominantly on bikes, Side-by-Sides, on-road vehicles with and without off-road capabilities, off-road vehicles and trucks, ATVs, snowmobiles, specialty vehicles and applications, motorcycles, and commercial trucks. Its business operates under the FOX, FOX RACING SHOX, and RACE FACE brands. Geographically, it derives a majority of revenue from North America and also has a presence in Asia, Europe, and the Rest of the World.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.